Quick Overview: What an incredible week it's been at the 51st Annual Meeting of Congress Co-Presidents Anna Sureda and Fabio Ciceri join 4. CAR in autoimmune disease Dr. Giorgio Orofino 14th Annual Conference of the SSBMT /

Highlights From Ebmt 2025 - Detailed Overview & Context

What an incredible week it's been at the 51st Annual Meeting of Congress Co-Presidents Anna Sureda and Fabio Ciceri join 4. CAR in autoimmune disease Dr. Giorgio Orofino 14th Annual Conference of the SSBMT / In this video, Anna Sureda, MD, PhD, Catalan Institute of Oncology, Duran I Reynals Hospital, Barcelona, Spain, looks forward to ... In this video, Raffaella Greco, MD, PhD, San Raffaele Hospital, Milan, Italy, briefly comments on how the Annual Meeting of the ... 08. New Era in Hemoglobinopathies Management Dr. Fahad Al Manjomi 14th Annual Conference of the SSBMT /

Gandhi Damaj, MD, PhD, University of Caen Normandie Hospital Center, Caen, France, comments on the 10. Timing of allo-HCT in Myelofibrosis: not too early, not too late Dr. Nicola Polverelli 14th Annual Conference of the SSBMT ... Alexandra Gomez-Arteaga, MD, Weill Cornell Medicine, New York, NY, discusses the future of stem cell transplantation (SCT) for ... In this video, Mairéad Ní Chonghaile, RGN, BNS, MSc, St James's Hospital, Dublin, Ireland, briefly shares some 06. CAR-T cell Treatment Strategies in Patient with Lymphomas Dr. Anna Sureda 14th Annual Conference of the SSBMT ...

Photo Gallery

Highlights from EBMT 2025
Highlights from the EBMT 2025 Closing Ceremony
Best Moments from Attendees of EBMT 2025
EBMT 2025 – Welcome from the Congress Co-Presidents
EBMT 2025 Basic Science Award Winner
Highlights from EBMT 2024
4. CAR in autoimmune disease | Dr. Giorgio Orofino | May 10, 2025
Looking forward to the fast-approaching 51st Annual Meeting of the EBMT
How the EBMT meeting is changing as the field of transplantation evolves
08. New Era in Hemoglobinopathies Management | Dr. Fahad Al Manjomi | May 9, 2025
The EBMT consensus guidelines for alloSCT in T-cell lymphoma
10. Timing of allo-HCT in Myelofibrosis: not too early, not too late | Dr. Nicola Polverelli | May 9
Sponsored
Sponsored
View Main Result
Sponsored
Sponsored